Evidence map›Paper›PMID 23707719›Full record

ArticleBiochemical and biophysical research communications2013

Id1 expression promotes peripheral CD4+ T cell proliferation and survival upon TCR activation without co-stimulation.

Chen Liu, Rong Jin, Hong-Cheng Wang, Hui Tang, Yuan-Feng Liu, Xiao-Ping Qian, Xiu-Yuan Sun, Qing Ge, Xiao-Hong Sun, Yu Zhang

Abstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Chen LiuDepartment of Immunology, Peking University Health Science Center, Beijing, China.
Rong Jin
Hong-Cheng Wang
Hui Tang
Yuan-Feng Liu
Xiao-Ping Qian
Xiu-Yuan Sun
Qing Ge
Xiao-Hong Sun
Yu Zhang
Peking University · CNOklahoma Medical Research Foundation · US

Funding

Notch-induced protein degradation in lymphopoiesisR01AI056129 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI SUN, XIAO-HONG · 2003 to 2013
$3.8M
NIAID NIH HHS AI56129NIAID NIH HHS R01 AI056129
6 · The paper itself

Abstract

Although the role of E proteins in the thymocyte development is well documented, much less is known about their function in peripheral T cells. Here we demonstrated that CD4 promoter-driven transgenic expression of Id1, a naturally occurring dominant-negative inhibitor of E proteins, can substitute for the co-stimulatory signal delivered by CD28 to facilitate the proliferation and survival of naïve CD4+ cells upon anti-CD3 stimulation. We next discovered that IL-2 production and NF-κB activity after anti-CD3 stimulation were significantly elevated in Id1-expressing cells, which may be, at least in part, responsible for the augmentation of their proliferation and survival. Taken together, results from this study suggest an important role of E and Id proteins in peripheral T cell activation. The ability of Id proteins to by-pass co-stimulatory signals to enable T cell activation has significant implications in regulating T cell immunity.

Indexed as

Gene Expression RegulationAnimalsCD28 AntigensCD3 ComplexCD4-Positive T-LymphocytesCell ProliferationCell SeparationCell SurvivalDose-Response Relationship, DrugFlow CytometryInhibitor of Differentiation Protein 1Interleukin-2Lymphocyte ActivationMiceMice, TransgenicNF-kappa BCD28 AntigensCD3 ComplexIdb1 protein, mouseInhibitor of Differentiation Protein 1Interleukin-2NF-kappa BReceptors, Antigen, T-Cell

Identifiers

PMID23707719
PMCPMC3955101
OpenAlexW1979744574

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.